Podcasts about christopher o'connor

Howie and Harlan are joined by Christopher O'Connor, CEO of Yale New Haven Health, to discuss his career path and his experience leading hospitals through Hurricane Katrina and COVID-19. Harlan reports on promising AI tools for taking clinical notes; Howie looks at the financial headwinds facing the companies offering Medicare Advantage plans.  Links: AI Notetaking “OpenAI-backed healthcare AI startup raises $70 million Series B” “Burnout Related to Electronic Health Record Use in Primary Care” “Ambient Artificial Intelligence Scribes to Alleviate the Burden of Clinical Documentation” “Medical AI scribe startup Nabla rolling out tool to the Permanente Medical Group docs in Northern California” “Ambience Healthcare reels in $70M for generative AI tools to battle clinician burnout” Hospital Leadership "After 20 Years and $16,000, A Hospital Debt Is Canceled" Harlan Krumholz: “Out‐of‐Pocket Annual Health Expenditures and Financial Toxicity From Healthcare Costs in Patients With Heart Failure in the United States” "Connecticut hospitals face record financial losses" "Update on Effect of Hurricane Katrina on Ochsner Clinic Foundation, LA" "YNHH and Hospital of Saint Raphael become one" Medicare Advantage “Humana slashes profit predictions amid soaring Medicare Advantage costs” HHS: “Biden-Harris Administration is Strengthening Medicare; Protecting and Serving America's Seniors” "Cano Health's downfall offers a warning for Medicare Advantage" CMS: Risk Adjustment Learn more about the MBA for Executives program at Yale SOM. Email Howie and Harlan comments or questions.

Howie and Harlan are joined by Christopher O'Connor, CEO of Yale New Haven Health, to discuss his career path and his experience leading hospitals through Hurricane Katrina and COVID-19. Harlan reports on promising AI tools for taking clinical notes; Howie looks at the financial headwinds facing the companies offering Medicare Advantage plans.  Links: AI Notetaking “OpenAI-backed healthcare AI startup raises $70 million Series B” “Burnout Related to Electronic Health Record Use in Primary Care” “Ambient Artificial Intelligence Scribes to Alleviate the Burden of Clinical Documentation” “Medical AI scribe startup Nabla rolling out tool to the Permanente Medical Group docs in Northern California” “Ambience Healthcare reels in $70M for generative AI tools to battle clinician burnout” Hospital Leadership "After 20 Years and $16,000, A Hospital Debt Is Canceled" Harlan Krumholz: “Out‐of‐Pocket Annual Health Expenditures and Financial Toxicity From Healthcare Costs in Patients With Heart Failure in the United States” "Connecticut hospitals face record financial losses" "Update on Effect of Hurricane Katrina on Ochsner Clinic Foundation, LA" "YNHH and Hospital of Saint Raphael become one" Medicare Advantage “Humana slashes profit predictions amid soaring Medicare Advantage costs” HHS: “Biden-Harris Administration is Strengthening Medicare; Protecting and Serving America's Seniors” "Cano Health's downfall offers a warning for Medicare Advantage" CMS: Risk Adjustment Learn more about the MBA for Executives program at Yale SOM. Email Howie and Harlan comments or questions.

Host Dr. Christopher O'Connor invites Drs. Scott Solomon, William Abraham, JoAnn Lindenfeld, Brian Claggett, Mona Fiuzat, and Mitchell Psotka to continue discussion of the importance of subgroups in heart failure clinical trials. How can we analyze subgroups and determine the differences between subgroups and special populations?

In which The Curmudgeons each reveal their favorite records of the year. Frankly, it was a mediocre past 12 months for popular music, and there aren't a whole lot of records people will remember a decade from now. Yet there were some gems, and during this moment in time, we're excited to share our picks. Call it a public service.    Enjoy a sampler platter of our selections via our Spotify playlist: https://open.spotify.com/playlist/1N5hCOovaIYE2uobAgvxVy?si=a80ada2729ab42c8   Here is a handy navigation companion for this episode:   (0:52 - 02:20) - Arturo Andrade sets the parameters for the episode   (02:20 - 10:17) - The Curmudgeons briefly discuss their pick for the worst album of 2023   (11:21 - 54:53) - Christopher O'Connor reveals his Top 10 albums of the year, including releases by Boygenius, Killer Mike and Zach Bryan   (56:26 - 01:29:02) - Arturo reveals his Top 10 albums of the year, including releases by Laurel Canyon, Mitski and Paul Simon. Yes, that Paul Simon...   Join our Curmudgeonly Community today! facebook.com/groups/curmudgeonrock   Hosted on Podbean! curmudgeonrock.podbean.com   Subscribe to our show on these platforms: https://podcasts.apple.com/us/podcast/the-curmudgeon-rock-report/id1551808911   https://open.spotify.com/show/4q7bHKIROH98o0vJbXLamB?si=5ffbdc04d6d44ecb   https://podcasts.google.com/feed/aHR0cHM6Ly9hbmNob3IuZm0vcy80M

Host Dr. Christopher O'Connor invites Drs. Javed Butler, Mariell Jessup, and Mitchell Psotka to discuss the importance of subgroups in heart failure clinical trials. How do we appropriately define subgroups? Which groups should be included as standard practice in HF trials?

Dr. Christopher O'Connor interviews the founding members of the data safety monitoring board (DSMB) training team, Dr. David DeMets, Dr. Janet Wittes, and Dr. Thomas Flemming, to continue discussing the importance of training the next generation in clinical trial leadership. Using their extensive experience in clinical trials, they address which practices will best serve future members, and the critical shortage of trained experts.

Drs. Janet Wittes, Mona Fiuzat, Maria Rosa Costanzo, Ana Barac, Barry Greenberg, Vanessa Blumer, and Michael Bristow come together on this episode with Dr. Christopher O'Connor to discuss initiatives to train the next generation of DSMB members. How do we pass on the experience and knowledge of seasoned DSMB members and properly train the next generation?

A new research paper was published in Aging (Aging-US) Volume 15, Issue 14, entitled, “Inhibiting NLRP3 signaling in aging podocytes improves their life- and health-span.” The decrease in the podocyte's lifespan and health-span that typify healthy kidney aging cause a decrease in their normal structure, physiology and function. The ability to halt and even reverse these changes becomes clinically relevant when disease is superimposed on an aged kidney. NLRP3 [nod-like receptor protein 3] expression is increased in podocytes of mice with advanced age and contributes to their damage. “However, the functional consequence of increased levels of NLRP3 in aged podocytes is unknown.” In this new study, researchers Natalya Kaverina, R. Allen Schweickart, Gek Cher Chan, Joseph C. Maggiore, Diana G. Eng, Yuting Zeng, Sierra R. McKinzie, Hannah S. Perry, Adilijiang Ali, Christopher O'Connor, Beatriz Maria Veloso Pereira, Ashleigh B. Theberge, Joshua C. Vaughan, Carol J. Loretz, Anthony Chang, Neil A. Hukriede, Markus Bitzer, Jeffrey W. Pippin, Oliver Wessely, and Stuart J. Shankland from the University of Washington, Cleveland Clinic Foundation, National University Hospital Singapore, University of Pittsburgh, University of Michigan, and the University of Chicago hypothesized that reducing NLRP3 signaling earlier at middle-age improves overall podocyte health and slows down healthy podocyte aging in mice. “To this end, we performed a comprehensive analysis of inflammasome signaling including pharmacological and genetic NLRP3 loss-of-function approaches.” RNA-sequencing of podocytes from middle-aged mice showed an inflammatory phenotype with increases in the NLRP3 inflammasome, signaling for IL2/Stat5, IL6 and TNF, interferon gamma response, allograft rejection and complement, consistent with inflammaging. Furthermore, injury-induced NLRP3 signaling in podocytes was further augmented in aged mice compared to young ones. The NLRP3 inflammasome (NLRP3, Caspase-1, IL1β IL-18) was also increased in podocytes of middle-aged humans. Higher transcript expression for NLRP3 in human glomeruli was accompanied by reduced podocyte density and increased global glomerulosclerosis and glomerular volume. Pharmacological inhibition of NLRP3 with MCC950, or gene deletion, reduced podocyte senescence and the genes typifying aging in middle-aged mice, which was accompanied by an improved podocyte lifespan and health-span. Moreover, modeling the injury-dependent increase in NLRP3 signaling in human kidney organoids confirmed the anti-senescence effect of MC9950. Finally, NLRP3 also impacted liver aging. “In summary, our results demonstrate for the first time that aging podocytes acquire an inflammatory phenotype, which include the NLRP3 inflammasome and which is consistent with inflammaging.” DOI - https://doi.org/10.18632/aging.204897 Corresponding authors - Oliver Wessely - wesselo@ccf.org, and Stuart J. Shankland - stuartjs@uw.edu Keywords - aging, kidney, podocyte, NLRP3 inflammasome, reporter About Aging-US Launched in 2009, Aging-US publishes papers of general interest and biological significance in all fields of aging research and age-related diseases, including cancer—and now, with a special focus on COVID-19 vulnerability as an age-dependent syndrome. Topics in Aging-US go beyond traditional gerontology, including, but not limited to, cellular and molecular biology, human age-related diseases, pathology in model organisms, signal transduction pathways (e.g., p53, sirtuins, and PI-3K/AKT/mTOR, among others), and approaches to modulating these signaling pathways. Visit our website at https://www.Aging-US.com​​ and connect with us: Facebook - https://www.facebook.com/AgingUS/ Twitter - https://twitter.com/AgingJrnl Instagram - https://www.instagram.com/agingjrnl/ YouTube - https://www.youtube.com/@AgingJournal LinkedIn - https://www.linkedin.com/company/aging/ For media inquiries, please contact: MEDIA@IMPACTJOURNALS.COM

Welcome to the Becker's Healthcare podcast, where Molly Gamble engages in a captivating conversation with Christopher O'Connor, President and CEO of Yale New Haven Health System. With an impressive background and deep experience within the organization, Christopher shares insights and lessons learned from his tenure as COO under the leadership of Marna Borgstrom, whom he succeeded as CEO. They delve into the dynamics of a healthy CEO-COO relationship and discuss the milestones that have shaped Christopher's first year in his current role. The conversation also explores the financial challenges faced by hospitals and health systems in 2022 and the anticipated impact over the next few years. Christopher sheds light on the pressing issues demanding his attention at Yale New Haven Health and highlights his concerns and priorities for the future. Join us for this engaging episode filled with valuable insights from a seasoned healthcare leader.

Drs. Mariell Jessup, JoAnn Lindenfeld, Maria Rosa Costanzo, Mona Fiuzat, Bill Abraham, and Wayne Batchelor join Christopher O'Connor to discuss the recruitment of women in HF clinical trials. What has been done so far and where do we go from here?

Transforming a healthcare system is no small task, but it's a worthwhile journey. Dr. Christopher O'Connor, President of Inova Heart and Vascular Institute, saw this firsthand when he began leading in a new environment. Affecting change requires alignment on mission and vision, releasing control for the greater good, and – above all – time. His past success helped him cast a compelling vision for his new team. With the support of his staff, he shifted the culture, adjusted hospital governance, and implemented a leadership academy. Gradually, he saw his small community hospital transform into a leader in cardiovascular care.

Drs. Peter Carson, JoAnn Lindenfeld, John Teerlink, Orly Vardeny, and Bill Abraham join Dr. Christopher O'Connor to discuss the implications of the FDA Advisory Committee meetings with special focus on three programs: TOPCAT (2:05), PARAGON-HF (15:53), and GALACTIC-HF (30:35).

When artist Christopher O'Connor arrived in Maine, one of the first things he did was to visit a few of the state's many islands. A native of Ireland, he soon noted the similarities and differences between the two coastlines. Christopher spent many childhood hours exploring the Irish seashore, clambering over ledges covered with moss and lichen, due to the country's persistent damp weather. He quickly became intrigued by the stark angularity of Maine's rocky coast, which proved a source of inspiration for his abstract yet intricate work. Join our conversation with Christopher O'Connor today on Radio Maine. Every week, Dr. Lisa Belisle brings you an interview with a member of Maine's community, including artists, designers, and more. Subscribe to Radio Maine on YouTube so you never miss an episode. Christopher O'Connor is represented by the Portland Art Gallery of Maine. Click here to view his art.

Join Drs. Christopher O'Connor, JoAnn Lindenfeld, Mitchell Psotka, Scott Solomon, Mona Fiuzat, Bill Abraham, and Peter Carson as they introduce a novel concept known as the Heart Failure Collaboratory (HFC) and discuss how it can contribute to the field of heart failure research.

lets GO. The D.A.W.G.Z. have gathered with dear friend Christopher O'Connor in a very comfortable setting to deliver a piping hot cast. Shane has suffered a very severe injury, and this is a pro-football podcast. Enjoy. Support the D.A.W.G.Z. @ patreon.com/MSsecretpod

Introducing the maiden voyage of The Curmudgeon Rock Report, wherein Christopher O'Connor and Arturo Andrade, longtime friends and unabashed rock 'n' roll nerds, introduce themselves and introduce the worldview that will govern this podcast. It's a love letter and break-up letter all at once. --- Send in a voice message: https://anchor.fm/curmudgeonly/message Support this podcast: https://anchor.fm/curmudgeonly/support

Episode Summary Continued... John Kane and Dan Bukszpan hosts of the incredible podcast Two Guys Talking Rush risk everything and broadcast live on this very special Thanksgiving week show! Our Guests include: Christopher O'Connor, founder of the Port Dalhousie Supply Company and O'Connor Initiative. David De Rocco Taskforce Chair joins the conversation as well. The incredible Donna Halper pops in as a surprise guest! Fans with Rush tattoos discuss why it was important to them to be forever inked with their favorite band. Awesome! Let us give thanks to Rush. Be well friends, JK & DB The PDSC Backstory... The Port Dalhousie Supply Company is a lifestyle apparel brand based in Niagara, Canada. We connect people to place through our works. There is a real “sense of place” in Port Dalhousie. Neil described that in Lakeside Park the song. The O'Connor Initiative is a non-profit organization that runs community events and special projects in Niagara. In partnership between our two companies we designed the Lakeside Park T-Shirt to honour the Art and Life of Neil Peart as he grew up in the area and was inspired by some of his surroundings. We didn't plaster Neil's name or face all over this shirt as we feel he would not have appreciated that, instead we made a classy ode to him through our own imagery. Willows in the breeze! What we hope to accomplish is to firstly connect people to the upcoming commemoration to Neil in Lakeside Park, Port Dalhousie. RUSH has a global fan base and they want to see Neil commemorated. Our shirts allow them to connect directly to the project, wherever they are! And hopefully bring their shirts when they make Port Dalhousie a travel destination. The City has struck a Taskforce to manage the project. Secondly, the proceeds from the t-shirts will directly benefit the project through the City. Shirts can be bought online at www.ptdalhousie.com www.twoguystalkingrush.com

John Kane and Dan Bukszpan hosts of the incredible podcast Two Guys Talking Rush risk everything and broadcast live on this very special Thanksgiving week show! Our Guests include: Christopher O'Connor, founder of the Port Dalhousie Supply Company and O'Connor Initiative. David De Rocco Taskforce Chair joins the conversation as well. The incredible Donna Halper pops in as a surprise guest! Fans with Rush tattoos discuss why it was important to them to be forever inked with their favorite band. Awesome! Let us give thanks to Rush. Be well friends, JK & DB The PDSC Backstory... The Port Dalhousie Supply Company is a lifestyle apparel brand based in Niagara, Canada. We connect people to place through our works. There is a real “sense of place” in Port Dalhousie. Neil described that in Lakeside Park the song. The O'Connor Initiative is a non-profit organization that runs community events and special projects in Niagara. In partnership between our two companies we designed the Lakeside Park T-Shirt to honour the Art and Life of Neil Peart as he grew up in the area and was inspired by some of his surroundings. We didn't plaster Neil's name or face all over this shirt as we feel he would not have appreciated that, instead we made a classy ode to him through our own imagery. Willows in the breeze! What we hope to accomplish is to firstly connect people to the upcoming commemoration to Neil in Lakeside Park, Port Dalhousie. RUSH has a global fan base and they want to see Neil commemorated. Our shirts allow them to connect directly to the project, wherever they are! And hopefully bring their shirts when they make Port Dalhousie a travel destination. The City has struck a Taskforce to manage the project. Secondly, the proceeds from the t-shirts will directly benefit the project through the City. Shirts can be bought online at www.ptdalhousie.com www.twoguystalkingrush.com

Mining is more than just an industry – it's been a way of life for people for generations. How can you look after your own legacy in your mining career? This week we chat to Christopher O'Connor, Director of Air Cleveland Compressed Services. Pete caught up to Chris at last year's Worthy Parts Industry Link […] The post EP.107 Chris O'Connor on Mining Through Generations and Building Your Mining Journey appeared first on Face Mining Services.

A young leader in cardiology interviews his former mentor, Christopher O'Connor, on what it means to be a good leader in medicine.